In vivo mapping of vascular inflammation using the translocator protein tracer 18F-FEDAA1106

Molecular Imaging

Volumn 13, Issue 6, 2014, Pages

  Cuhlmann, Simon ^a   Gsell, Willy ^a   Van Der Heiden, Kim ^a   Habib, Josef ^a   Tremoleda, Jordi L ^a   Khalil, Magdy ^a   Turkheimer, Federico ^a   Meens, Merlijn J ^a   Kwak, Brenda R ^a   Bird, Joseph ^a   Davenport, Anthony P ^a   Clark, John ^a   Haskard, Dorian ^a   Krams, Rob ^a   Jones, Hazel ^a   Evans, Paul C ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; MACROPHAGES; TRACERS;

ACTIVATED MACROPHAGES; ATHEROSCLEROTIC PLAQUE; COMPUTED TOMOGRAPHIC; GLUCOSE METABOLISM; NON-INVASIVE IMAGING; POSITRON EMISSION; SELECTIVE LIGANDS; STANDARDIZED UPTAKE VALUES;

PATHOLOGY;

ACETAMIDE DERIVATIVE; FLUORODEOXYGLUCOSE F 18; N-(5-FLUORO-2-PHENOXYPHENYL)-N-(2-FLUOROETHYL-5-METHOXYBENZYL)ACETAMIDE; RADIOPHARMACEUTICAL AGENT;

ANIMAL; C57BL MOUSE; CAROTID ARTERY; DISEASE MODEL; HUMAN; METABOLISM; MOUSE; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

ACETAMIDES; ANIMALS; CAROTID ARTERIES; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; HUMANS; MICE; MICE, INBRED C57BL; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84907210971     PISSN: 15353508     EISSN: 15360121     Source Type: Journal    
DOI: 10.2310/7290.2014.00014     Document Type: Article

References (27)

1. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74, doi:10.1038/nature01323.
2. Cuhlmann S, Van der Heiden K, Saliba D, et al. Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-kappa B regulation that promotes arterial inflammation. Circ Res 2011;108:950-9, doi:10.1161/CIRCRESAHA.110.233841.
3. Cheng C, van Haperen R, de Waard M, et al. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood 2005;106:3691-8, doi:10.1182/blood-2005-06-2326.
4. Cheng C, Tempel D, van Haperen R, et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006;113:2744-53, doi:10.1161/CIRCULATIONAHA.105.590018.
5. Rudd JH, Narula J, Strauss HW, et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography. J Am Coll Cardiol 2010;55:2527-35, doi:10.1016/j.jacc.2009.12.061.
6. Ogawa M, Ishino S, Mukai T, et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 2004;45:1245-50.
7. Rudd JH, Myers KS, Bansilal S, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/ computed tomography imaging study. Circ Cardiovasc Imaging 2009;2:107-15, doi:10.1161/CIRCIMAGING.108.811752.
8. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818-24, doi:10.1016/j.jacc.2006.05.076.
9. Benavides J, Fage D, Carter C, Scatton B. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res 1987;421:167-72, doi:10.1016/0006-8993(87)91287-X.
10. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006;27:402-9, doi:10.1016/j.tips.2006.06.005.
11. Zavala F, Haumont J, Lenfant M. Interaction of benzodiazepines with mouse macrophages. Eur J Pharmacol 1984;106:561-6, doi:10.1016/0014-2999(84)90059-1.
12. Pugliese F, Gaemperli O, Kinderlerer AR, et al. Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/ computed tomography angiography. J Am Coll Cardiol 2010;56:653-61, doi:10.1016/j.jacc.2010.02.063.
13. Junck L, Olson JM, Ciliax BJ, et al. PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol 1989;26:752-8, doi:10.1002/ana.410260611.
14. Pappata S, Levasseur M, Gunn RN, et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology 2000;55:1052-4, doi:10.1212/WNL.55.7.1052.
15. Laitinen I, Marjamäki P, Någren K, et al. Uptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques. Eur J Nucl Med Mol Imaging 2009;36:73-80, doi:10.1007/s00259-008-0919-6.
16. Fujimura Y, Hwang PM, Trout Iii H, et al. Increased peripheral benzodiazepine receptors in arterial plaque of patients with atherosclerosis: an autoradiographic study with [H-3]PK 11195. Atherosclerosis 2008;201:108-11, doi:10.1016/j.atherosclerosis.2008.02.032.
17. Bird JL, Izquierdo-Garcia D, Davies JR, et al. Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis. Atherosclerosis 2010;210:388-91, doi:10.1016/j.atherosclerosis.2009.11.047.
18. Lamare F, Hinz R, Gaemperli O, et al. Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET/CT. J Nucl Med 2011;52:33-9, doi:10.2967/jnumed.110.079038.
19. Feldkamp LA, Davis LC, Kress JW. Practical cone-beam algorithm. J Opt Soc Am Optic Image Sci Vis 1984;1:612-9, doi:10.1364/ JOSAA.1.000612.
20. Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 2000;27:661-70, doi:10.1016/S0969-8051(00)00137-2.
21. Chauveau F, Boutin H, Van Camp N, et al. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging 2008;35:2304-19, doi:10.1007/s00259-008-0908-9.
22. Tomasi G, Edison P, Bertoldo A, et al. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer disease. J Nucl Med 2007;48:158-67.
23. Kropholler MA, Boellaard R, Elzinga EH, et al. Quantification of (R)-[11C]-PK11195 binding in rheumatoid arthritis. Eur J Nucl Med Mol Imaging 2009;36:624-31, doi:10.1007/s00259-008-0987-7.
24. Turkheimer FE, Edison P, Pavese N, et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J Nucl Med 2007;48:158-67.
25. Venneti S, Wagner AK, Wang G, et al. The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: implications for PET imaging. Exp Neurol 2007;207:118-27, doi:10.1016/j.expneurol.2007.06.003.
26. Zhang MR, Kida T, Noguchi J, et al. [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. Nucl Med Biol 2003;30:513-9, doi:10.1016/S0969-8051(03)00016-7.
27. Takano A, Gulyas B, Varrone A, et al. Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study. Eur J Nucl Med Mol Imaging 2011;38:2058-65, doi:10.1007/s00259-011-1864-3.